Document is current
Any future updates will be listed below
-
Authors
Quattrocchi, Carlo C. https://orcid.org/0000-0001-6823-7707
Rovira, Àlex
van der Molen, Aart J.
Mallio, Carlo A.
- License Information
-
More Information
Article History
Received: 1 July 2024
Revised: 8 October 2024
Accepted: 18 October 2024
First Online: 19 December 2024
Compliance with ethical standards
:
: The scientific guarantor of this publication is Carlo C. Quattrocchi, the first and corresponding author.
: Carlo Cosimo Quattrocchi has signed speaker contracts with Bayer Healthcare, Bracco Imaging, and Guerbet. He is co-chair of the ESMRMB-GREC working group whose yearly meetings have received unconditional support from Bayer Healthcare, Bracco Imaging, GE HealthCare, and Guerbet. He is a member of the ESUR-CMSC whose 2-yearly meetings have received support from Bayer Healthcare, Bracco Imaging, GE HealthCare, and Guerbet. Àlex Rovira served on scientific advisory boards and has received speaker honoraria from Bayer Healthcare, Sanof-Genzyme, Bracco Imaging, Merck-Serono, Teva Pharmaceutical Industries Ltd., Novartis, Roche, and Biogen. Aart J. van der Molen received consultancy fees from Guerbet as a member of the Expert Group for Gadopiclenol in the Netherlands. He is a member of the ESUR-CMSC whose 2-yearly meetings have received support from Bayer Healthcare, Bracco Imaging, GE HealthCare, and Guerbet. Carlo Augusto Mallio does not have any conflict of interest to disclose.
: No complex statistical methods were necessary for this paper.
: Written informed consent was not required for this study.
: Institutional Review Board approval was not required.
: Not applicable.
:
